Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 2/3 1Phase 1/2 1

Status

Completed 67Recruiting 14Terminated 10Withdrawn 9Unknown 6Active not recruiting 6Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Tumor-Agnostic 3Gastrointestinal 2Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 80Nasopharyngeal Carcinoma 51Uterine Cervical Neoplasms 43Lung Neoplasms 38Esophageal Neoplasms 31Head and Neck Neoplasms 28Esophageal Squamous Cell Carcinoma 27Squamous Cell Carcinoma of Head and Neck 22Stomach Neoplasms 20Breast Neoplasms 16Small Cell Lung Carcinoma 15Neoplasm Metastasis 12Nasopharyngeal Neoplasms 12Recurrence 11Carcinoma, Squamous Cell 10Ovarian Neoplasms 9Central Nervous System Neoplasms 9Neuroblastoma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma 7Hypopharyngeal Neoplasms 7Triple Negative Breast Neoplasms 6Pancreatic Neoplasms 6Oropharyngeal Neoplasms 6Neoplasms 6Biliary Tract Neoplasms 6Urinary Bladder Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5

Interventions

Exercise 18Drug Therapy 17pembrolizumab 12Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Dexamethasone 9Paclitaxel 8Standard of Care 7Oxaliplatin 7Nivolumab 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Control Groups 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Cisplatin × Clear all
NCT05241132 2022-02-15

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

Shanghai Changzheng Hospital

Phase 2 Unknown
27 enrolled
Tumor-Agnostic

Neoplasms

NCT03469531 2018-08-13

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Zhujiang Hospital

Phase 2 Unknown
100 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Neoplasms

NCT02644863 2016-05-24

Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

Shenzhen Hornetcorn Bio-technology Company, LTD

Phase 2 Unknown
60 enrolled
Gastrointestinal

Digestive System Neoplasms, Esophageal Neoplasms, Neoplasms

NCT02250872 2016-04-20

Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury

Seoul National University Bundang Hospital

Phase 2/3 Unknown
182 enrolled
Tumor-Agnostic

Neoplasms

NCT00178763 2011-03-03

FR-WB-TT

The University of Texas Health Science Center, Houston

Phase 2 Unknown
36 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00845884 2009-02-18

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

Rabin Medical Center

Phase 1/2 Unknown
49 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡